Dalrada Technology Group, Inc.
No enriched coverage for $DHTI in the last 7 days.
No SEC Form 4 filings for $DHTI in the last 30 days.
See all $DHTI insider activity →Dalrada Technology Group (DHTI) settled with IBS Equity Fund III and IBS Private Credit Fund IV for $20,000, resolving disputes and terminating financing agreements. The deal, effective Oct. 2, 2026, canceled notes, warrants, and released liens. IBS withdrew default notices, confirming no remaining rights in Dalrada.
Dalrada Technology Group, Inc. (DHTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Item 1.02 Termination of a Material Definitive Agreement. As previously reported in the Current Report on Form 8-K filed by Dalrada Technology Group, Inc. (the “Company”) on September 22, 2026 (the “Prior 8-K”), effective as o
Dalrada Technology Group, Inc. (DHTI) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. Item 1.02 Termination of a Material Definitive Agreement. Effective as of December 31, 2025, Genefic, Inc. (“Genefic”), a wholly owned subsidiary of Dalrada Technology Group, Inc. (the “Company”), together with certain of Genefic’s affiliates and subsidiaries, entered into (i) a
Recent DHTI coverage spans corporate actions and financial news.
The settlement removes outstanding financing obligations and liens, likely clearing any short‑term uncertainty but the modest amount suggests minimal market impact.
The settlement removes outstanding obligations and eliminates a financing relationship, but the modest settlement amount limits market impact.
Potential liability and cash outflow could pressure Dalrada's balance sheet and share price.
AlphAI scores every news story that mentions DHTI with an AI model for sentiment and relevance, and aggregates insider trades from Dalrada Technology Group, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Dalrada Technology Group (DHTI) settled with IBS Equity Fund III and IBS Private Credit Fund IV for $20,000, resolving disputes and terminating financing agreements. The deal, effective Oct. 2, 2026, canceled notes, warrants, and released liens. IBS withdrew default notices, confirming no remaining rights in Dalrada.
1 min readDalrada Technology Group, Inc. (DHTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Item 1.02 Termination of a Material Definitive Agreement. As previously reported in the Current Report on Form 8-K filed by Dalrada Technology Group, Inc. (the “Company”) on September 22, 2026 (the “Prior 8-K”), effective as o
1 min readDalrada Technology Group, Inc. (DHTI) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. Item 1.02 Termination of a Material Definitive Agreement. Effective as of December 31, 2025, Genefic, Inc. (“Genefic”), a wholly owned subsidiary of Dalrada Technology Group, Inc. (the “Company”), together with certain of Genefic’s affiliates and subsidiaries, entered into (i) a
1 min read
